Cytosorbents (CTSO) Shares Outstanding (2010 - 2026)

Cytosorbents (CTSO) has 17 years of Shares Outstanding (Entity) data on file, last reported at $62.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.33% year-over-year to $62.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.7 million (changed 0.33% YoY) and the FY2025 annual result came in at $62.8 million, up 14.54% from the prior year.
• Shares Outstanding (Entity) steadied at $62.7 million in Q1 2026, from $62.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $62.8 million in Q4 2025 to a low of $43.5 million in Q1 2022.
• A 5-year average of $51.9 million and a median of $54.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) advanced 23.81% — and 2026, when it increased 0.33%.
• Tracing CTSO's Shares Outstanding (Entity) over 5 years: stood at $43.6 million in 2022, then advanced by 2.34% to $44.7 million in 2023, then advanced by 22.78% to $54.8 million in 2024, then advanced by 14.54% to $62.8 million in 2025, then retreated by 0.11% to $62.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $62.7 million (Q1 2026), $62.8 million (Q4 2025), and $62.8 million (Q3 2025), per Business Quant data.